EP2861599
REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
:
EP einkaleyfi: Þýðing ekki lögð inn:
11.6.2013:
18.12.2019:
13731218.7
:
10.6.2033
:
REVERSIBLE COVALENT PYRROLO- OR PYRAZOLOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
11.6.2013
18.12.2019
:
Principia Biopharma Inc.:
220 E. Grand Ave., S. San Francisco, CA 94080, US
:
GOLDSTEIN, David Michael:
Redwood City, California 94061, US
:
BERNER, Bret:
Seattle WA 98116, US
:
201261661203 P:
18.6.2012:
US
:
US2013045266:
11.6.2013
:
C07D 487/04, A61K 31/519, A61P 35/00, A61P 37/06